[1] Alberola V, Cortesi E, Juan O. Weekly paclitaxel in the treatment of metastatic and/or recurrent non-small celllung cancer [J]. Crit Rev Oncol Hematol, 2002, 44 Suppl: 31-41.
[2] Bell MC, Davidson SA, Mathis JM, et al. Topotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma: a phase I tria [J]. Gynecol Oncol, 2001, 80: 128-131.
[3] Calderoni A and Cerny T. Taxanes in lung cancer: a review with focus on the European experience [J]. Crit Revi Oncol Hematol, 2001, 38: 105-127.
[4] Cartee L, Davis C, Lin PS, et al. Chronic exposure to bryostatin-1 increases the radiosensitivity of U937 leukaemia cells ectopically expressing Bcl-2 through a non-apoptotic mechanism [J]. Int J Radiat Biol, 2000, 76: 1323-1333.
[5] Chen Y, Pandya K, Keng PP, et al. Schedule-dependent pulsed paclitaxel radiosensitization for thoracic malignancy [J]. Am J Clin Oncol, 2001, 24: 432-437.
[6] Crane CH, Janjan NA, Mason K, et al. Preoperative chemoradiation for locally advanced rectal cancer: emerging treatment strategies [J]. Oncology ( Huntingt), 2002, 16: 39-44.
[7] Ding ZJ, Su Y, Yin Q, et al. Observation of the close effect of radiotherapy combined with Antike on esophageal carcinoma [J]. Chin J Prev Treat, 2000, 7: 638-639.
[8] Dunton CJ, King SA, Neufeld J, et al. Phase I study of topotecan and radiation therapy in advanced cervical cancer [J]. Gynecol Oncol, 2002, 85: 185-187.
[9] Fan MQ and Liu LP. Radiosensitizing effects of antike on nasopharyngeal carcinoma [J]. J North Chin Coal Med College, 2001, 3: 750-751.
[10] He HJ, He HF, Huang CJ, et al. The effect of radiosensitization of scorpion toxin [J]. Prac J Med Pharm, 2002, 19: 129-131.
[11] Hu GQ, Yuan XL, Hu CY. Clinical observation of Antike combined with radiotherapy on nasopharyngeal carcinoma [J]. Chin J Clin Oncol, 2002, 29: 440-441.
[12] Huober JB, Nakamura S, Meyn R, et al. Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer [J]. Int J Radiat Oncol Biol Phys, 2000, 48: 1127-1137.
[13] KimJS, Amorino GP, Pyo H, et al. The novel taxane analogs, BMS-184476 and BMS-188797, potentiate the effects of radiation therapy in vitro and in vivo against human lung cancer cells [J]. Int J Radiat Oncol Biol Phys, 2001, 51: 525-534.
[14] Kohara H, Tabata M, Kiura K, et al. Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell line [J]. Clin Cancer Res, 2002, 8: 287-292.
[15] Langer CJ, Ruffer J, Rhodes H, et al. Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme [J]. Int J Radiat Oncol Biol Phys,2001, 51: 113-119.
[16] Li XY, Wang Y, Yu LH, et al. Treatment of esophageal carcinoma with irisquinones combined radiotherapy [J]. Chin J Clin Oncol, 2000, 5: 272-274.
[17] Li AA, Lin YZ, Hu YH. Clinical observation of irisquinones combined with radiotherapy on esophageal carcinoma [J]. Chin J Clin Oncol Rehab, 2001, 8: 20.
[18] Li Q, Xie YH, Sun J Y, et al. Mechanism of radiosensitizing effect of Andi [J]. West Chin J Pharm Sci, 2003, 18: 6-9.
[19] Lin HM, Zhu SF, Chen ZH. Effect analysis of combined irisquinone and radiotherapy for middle and late stage nasopharyngeal cancer [J]. Chin J Clin Oncol, 2001, 28: 439-440.
[20] Liu LH and Yang XF. Effects of irisquinone combined with radiotherapy on esophageal cancers of 112 patients [J]. Acta Med Sin, 2000, 13: 467-468.
[21] Liu XQ, Hao JF, Zhai LM, et al. The study on late course accelerated hyperfraction radiotherapy in combination with Anka in nasopharyngeal carcinoma. [J] Chin J Cancer Prev Treat, 2000, 7: 469-472.
[22] Liu J. New advancement of pacitaxel combined radiotherapy in head and neck cancers [J]. Foreign Med Sci (Otorhinolaryng), 2002, 26: 5-7.
[23] Mao XW, Green LM, Gridley DS. Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation [J]. Oncology, 2001, 61: 243-253.
[24] Ning C and Xu F. Observation of 30 patients with niddle and later stage lung cancers treated with irisquinone combined radiotherapy [J]. J Pract Trad Chin Med, 2000, 16: 7.
[25] Pond-Tor S, Rhodes RG, Dahlberg PE, et al. Enhancement of radiosensitivity of the MCF-7 breast cancer cell line with human chorionic gonadotropin [J]. Breast Cancer Res Treat, 2002, 72: 45-51.
[26] Pradier O, Rave-Frank M, Lehmann J, et al. Effects of docetaxel in combination with radiation on human head and neck cancer cells (ZMK-1) and cervical squamous cell carcinoma cells (CaSki ) [J]. Int J Cancer, 2001, 91: 840-845.
[27] Qi C, Han QC, He HJ, et al. Study on radiosensitization and thermosensitization of scorpion toxin [J]. J Postgrad Med, 2000, 23: 30-32.
[28] Qi WQ, Qiao DH, Martinez JD. Caffeine induces TP53-independent G(1)-phase arrest and apoptosis in human lung tumor cells in a dose-dependent manner [J]. Radiat Res,2002, 157: 166-174.
[29] Qu YQ, Dong LH, Li BY, et al. Present effects observing of Aidi Chinese herb plus radiotherapy for advanced esophageal cancer in aging [J]. Chin J Gerontol, 2001, 21: 33-34.
[30] Raitanen M, Rantanen V, Kulmala J, et al. Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines [J]. Int J Cancer, 2002, 97: 853-857.
[31] Ren ZY, Bai CX, Hong QY, et al. The radiosensitization of docetaxel on Lewis lung cancer in vivo [J]. J Radiat Res Radiat Process, 2002, 20: 191-196.
[32] Safran H, Wanebo HJ, Hesketh PJ, et al. Paclitaxel and concurrent radiation for gastric cancer [J]. Int J Radiat Oncol Biol Phys, 2000, 46: 889-894.
[33] Safran H, Moore T, Iannitti D, et al. Paclitaxel and concurrent radiation for locally advanced pancreatic cancer [J]. Int J Radiat Oncol Biol Phys, 2001, 49: 1275-1279.
[34] Schuck A, Muller SB, Kohler A, et al. Combined radiochemotherapy with paclitaxel in the treatment of malignant glioma [J]. Strahlenther Onkol, 2002, 178: 486-490.
[35] Shi YQ, Blattmann H, Crompton NE. Wortmannin selectively enhances radiation-induced apoptosis in proliferative but not quiescent cellsv [J]. Int J Radiat Oncol Biol Phys, 2001, 49: 421-425.
[36] Stuben G, Thews O, Pottgen C, et al. Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice [J]. J Cancer Res Clin Oncol, 2001, 127: 346-350.
[37] Sun LF, Sun Y, Shen WJ, et al. Effect of the mixture of toad skin and Chinese angelic on radiosensitivity of renal cell lines and its mechanisms [J]. Chin J Clin Oncol Rehab, 2000, 7: 1-3.
[38] Talla M, MangoldM, Angellier E, et al. Acute cutaneous reactions induced by docetaxel: a case report [J]. Therapie,2001, 56: 632-633.
[39] Varterasian ML, Mohammod RM, Shurafa MS, et al. Phase II trail of bryostatin 1 in patients with relapsed low grade nonHodgkin’s lymphoma and chronic lymphocytic leukemia [J]. Clin Cancer Res, 2000, 6: 825.
[40] Wall NR, Mohammod RM, Reddy KB, et al. Bryostatin 1 induced ubiquitization and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line [J]. Int J Mol Med, 2000, 5: 165.
[41] Wu HGand Choy H. Irinotecan in combination with radiation therapy for small-cell and non-small-cell lung cancer [J]. Oncology ( Huntingt), 2002, 16: 13-18.
[42] Xu J, Chen ZH, Lin HR, et al. Radiotherapy combined with Antike for esophageal cancer [J]. Chin J Cancer Prev Treat, 2002, 9: 528-529.
[43] Zhou YQ and Bian XH. Clinical study on NPC radiosensitization of irisquinones [J]. Acta Univ Med Nanjing, 2001, 21: 328-330. |
>
>